GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lin BioScience Inc (ROCO:6696) » Definitions » Cash Flow from Discontinued Operations

Lin BioScience (ROCO:6696) Cash Flow from Discontinued Operations : NT$0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Lin BioScience Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Lin BioScience's cash flow from discontinued operations for the six months ended in Jun. 2023 was NT$0.00 Mil. It means Lin BioScience received NT$0.00 Mil from the sale of part of business quarterly. Lin BioScience's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Jun. 2023 was NT$0.00 Mil.

Lin BioScience Cash Flow from Discontinued Operations Historical Data

The historical data trend for Lin BioScience's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lin BioScience Cash Flow from Discontinued Operations Chart

Lin BioScience Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial - - - - -

Lin BioScience Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Lin BioScience Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lin BioScience Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Lin BioScience's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Lin BioScience (ROCO:6696) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lin BioScience Inc (ROCO:6696) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
TPE:1760 ROCO:6535 ROCO:6885 ROCO:6875 TPE:6541 ROCO:4157 ROCO:4728 ROCO:4726 ROCO:6838 ROCO:3176 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Zhongxiao East Road, 12th Floor, No. 68, Section 5, Xinyi District, Taipei City, TWN, 110
Website
https://www.linbioscience.com
Lin BioScience Inc is a drug development company. It specializes in therapies for diseases with unmet medical needs. Its novel pipeline consists of first-in-class drugs aimed at treating life-threatening or disabling diseases in oncology, ophthalmology, cardiovascular, and metabolic disease.

Lin BioScience (ROCO:6696) Headlines

No Headlines